Linda Evangelista Appointed as New Creative Director for ERASA XEP-30

BioMimetic Laboratories’ revolutionary skincare product adds fashion and beauty icon to product innovation and brand management team.

Elle.com coverage (EN)

Erasa website (EN)

Press release (EN) :

BioMimetic Laboratories, an incubated company of leading skincare innovator Skyler Brand Ventures, announced that Linda Evangelista will join the team of ERASA XEP- 30 as Vice President and Creative Director. ERASA XEP-30 is a revolutionary prestige skincare concentrate whose formulation includes a range of powerful anti-aging ingredients designed to deliver a total activity of anti-aging benefits.

The product is the brainchild of leading chemists and won the prestigious Allure Best of Beauty Breakthrough award within four months of its launch last summer.

In her new role, Ms. Evangelista will be an integral member of the product innovation team, bringing forth her eminent knowledge of the beauty and fashion industries as well as deeply personal experiences in using skincare products to help the ERASA scientific team innovate products with clinically proven superiority and direct relevance to today’s women.

“I have been an avid fan and user of ERASA since a friend gifted the product to me last year. As someone who has had the amazing opportunity to work with incredible brands and industry leaders, I’m most excited and humbled to be a part of the ERASA family because it is wholeheartedly a product I believe in and stand behind based on the true and lasting improvements I have seen in my skin. I aspire to elevate and bring awareness to the brand so that women everywhere can benefit from the outstanding results,” stated Ms. Evangelista.

The addition of such an industry legend to the ERASA team underscores our deep commitment to the development of truly groundbreaking new products in prestige anti-aging. We believe Linda will tremendously enhance the quality of the products in our pipeline and expect her expertise to have an immediate impact on product creation,” stated Jules Zecchino, Founder of Skyler Brand Ventures and the Chief Technology Officer for BioMimetic Laboratories.

BioMimetic Laboratories is a venture-backed startup from the portfolio of Skyler Brand Ventures, the premier R&D incubator in the cosmetics industry. Its lead investor is Valmiki Capital Management, a New York based asset manager.

Ravi Suria, Valmiki’s Managing Partner and BioMimetic Laboratories’ founding investor stated, “We were thrilled to add an industry legend to the team lead by a peerless industry scientist — our investment is predicated on the belief that Jules Zecchino’s team is creating cutting edge skincare products and bringing in the fashion industry expertise of Linda Evangelista will create a truly disruptive brand that will lead the industry in pioneering products for a very long time.”

Ms. Evangelista is an inspiration and role model for women. Aside from her prestige and extreme accomplishments as a supermodel, Ms. Evangelista is an activist for HIV/AIDS research as well as breast cancer awareness. Her collaboration with ERASA XEP-30 will lend the utmost credibility and awareness to consumers.

Reference (EN)

About BioMimetic Laboratories

BioMimetic Laboratories is a venture-backed company from the portfolio of Skyler Brand Ventures, the premier R&D incubator in the cosmetics industry. Its lead investor is Valmiki Capital Management, a New York based asset manager. Ravi Suria, Valmiki’s Managing Partner and BioMimetic Laboratories’ founding investor stated, “We were thrilled with clinical results of the first product to come from BioMimetic Laboratories and feel gratified that the industry experts agree with the marketplace’s assessment. We invested in Skyler’s companies to back the preeminent scientist in the cosmetics industry and are extremely pleased with the technology and products created by Jules Zecchino and his research teams.”

About Activen SA

Activen SA, Lausanne, Switzerland, discovers, develops and markets high efficiency biomimetic cosmetic actives for the cosmetic industry. The first line of XEP®-018/030 product is a muscle relaxant peptide with Botox-like effect derived from shellfish venoms.

About Remora Capital SA

Remora Capital SA, Lausanne, Switzerland, is an independent entrepreneurial investment company specialized in health and beauty innovation. Leveraging on its entrepreneurial, industrial and scientific expertise, it provides hands-on, sustainable and value-creative support to innovative companies in Switzerland and surrounding countries.